264 related articles for article (PubMed ID: 25243524)
1. Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain.
Kuhad A; Singh P; Chopra K
Expert Opin Ther Targets; 2015 Feb; 19(2):177-85. PubMed ID: 25243524
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase inhibitors: a patent review (2011 - 2013).
Li NG; Tang YP; Duan JA; Shi ZH
Expert Opin Ther Pat; 2014 Sep; 24(9):1039-52. PubMed ID: 25098768
[TBL] [Abstract][Full Text] [Related]
3. MMPs: a novel drug target for schizophrenia.
Chopra K; Baveja A; Kuhad A
Expert Opin Ther Targets; 2015 Jan; 19(1):77-85. PubMed ID: 25214056
[TBL] [Abstract][Full Text] [Related]
4. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
5. Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?
Solanki A; Bhatt LK; Johnston TP; Prabhavalkar KS
Curr Protein Pept Sci; 2019; 20(4):324-333. PubMed ID: 30215334
[TBL] [Abstract][Full Text] [Related]
6. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
[TBL] [Abstract][Full Text] [Related]
8. Curcumin: a potential candidate for matrix metalloproteinase inhibitors.
Kumar D; Kumar M; Saravanan C; Singh SK
Expert Opin Ther Targets; 2012 Oct; 16(10):959-72. PubMed ID: 22913284
[TBL] [Abstract][Full Text] [Related]
9. Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels.
Singh P; Bansal S; Kuhad A; Kumar A; Chopra K
Food Funct; 2020 May; 11(5):4548-4560. PubMed ID: 32400767
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
Chen Y; Peng W; Raffetto JD; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
[TBL] [Abstract][Full Text] [Related]
11. Status of research on matrix metalloproteinases (MMPs) in India.
Bulbule A; Saraswati S; Kundu GC
Expert Opin Ther Targets; 2011 Jun; 15(6):671-5. PubMed ID: 21476880
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
[TBL] [Abstract][Full Text] [Related]
13. Activated microglia in the spinal cord underlies diabetic neuropathic pain.
Wang D; Couture R; Hong Y
Eur J Pharmacol; 2014 Apr; 728():59-66. PubMed ID: 24508519
[TBL] [Abstract][Full Text] [Related]
14. N-acetyl-cysteine attenuates neuropathic pain by suppressing matrix metalloproteinases.
Li J; Xu L; Deng X; Jiang C; Pan C; Chen L; Han Y; Dai W; Hu L; Zhang G; Cheng Z; Liu W
Pain; 2016 Aug; 157(8):1711-1723. PubMed ID: 27075430
[TBL] [Abstract][Full Text] [Related]
15. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
Leppert D; Lindberg RL; Kappos L; Leib SL
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
Yang JS; Lin CW; Su SC; Yang SF
Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787
[TBL] [Abstract][Full Text] [Related]
18. Vascular extracellular matrix in atherosclerosis.
Chistiakov DA; Sobenin IA; Orekhov AN
Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.
MacColl E; Khalil RA
J Pharmacol Exp Ther; 2015 Dec; 355(3):410-28. PubMed ID: 26319699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
